Lung Carcinoma Clinical Trial
Official title:
Reducing PM2.5 Exposure and Lung Cancer Risk Using Spatial Data Science (The Air Study)
Verified date | July 2022 |
Source | Fred Hutchinson Cancer Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This clinical trial will conduct an educational intervention to promote knowledge of and preventive health behaviors related to personal air pollution exposure. Air pollution is n ubiquitous environmental exposure that is associated with harmful health effects including lung cancer. The educational intervention is comprised of 2 educational videos that include information regarding air pollution, health effects, and personal preventive health behaviors to reduce air pollution exposure and the use of a wearable air pollution sensor. The knowledge gained from this study may inform future research that will be designed to promote awareness of air pollution and its health effects.
Status | Completed |
Enrollment | 25 |
Est. completion date | March 5, 2022 |
Est. primary completion date | January 10, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adults 18 years or older: The evidence for personal strategies to reduce air pollution exposure has been focused on adults - Live in Seattle, WA: The study is designed to focus on Seattle, WA such as using EnviroFlash alerts - Own a smartphone: The participant requires a smartphone to setup the Flow app for the air pollution sensor - Not traveling in the near-term: The study is designed to assess air pollution patterns in the local Seattle area - Leave your home for at least 7 hours per week: Participants will use a wearable air pollution sensor to measure air pollutant levels from indoor and outdoor sources |
Country | Name | City | State |
---|---|---|---|
United States | Fred Hutch/University of Washington Cancer Consortium | Seattle | Washington |
Lead Sponsor | Collaborator |
---|---|
Fred Hutchinson Cancer Center | Prevent Cancer Foundation |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in knowledge regarding air pollution | Will calculate the proportion of the items that were answered correctly. McNemar's tests will be used to calculate differences in the proportion of participants answering air pollution knowledge items correctly at baseline and at week 5. | At baseline and week 5 | |
Primary | Changes in air pollution preventive health behaviors | Will calculate summary scores for air pollution preventive health behaviors and paired t-test to determine intervention effectiveness at baseline and at week 5. | At baseline and week 5 | |
Secondary | Changes in perceived barriers | Summary scores for perceived barriers (guided by the Health Belief Model) will be calculated from participant questionnaire responses by summing the scores across the relevant scale. Paired t-tests will determine changes in perceived barriers at baseline and week 5. | At baseline and week 5 | |
Secondary | Changes in perceived benefits | Summary scores for perceived benefits (guided by the Health Belief Model) will be calculated from participant questionnaire responses by summing the scores across the relevant scale. Paired t-tests will determine changes in perceived benefits at baseline and week 5. | At baseline and week 5 | |
Secondary | Changes in perceived susceptibility | Summary scores for perceived susceptibility (guided by the Health Belief Model) will be calculated from participant questionnaire responses by summing the scores across the relevant scale. Paired t-tests will determine changes in perceived susceptibility at baseline and week 5. | At baseline and week 5 | |
Secondary | Changes in perceived severity | Summary scores for perceived severity (guided by the Health Belief Model) will be calculated from participant questionnaire responses by summing the scores across the relevant scale. Paired t-tests will determine changes in perceived severity at baseline and week 5. | At baseline and week 5 | |
Secondary | Changes in self-efficacy | Summary scores for self-efficacy (guided by the Health Belief Model) will be calculated from participant questionnaire responses by summing the scores across the relevant scale. Paired t-tests will determine changes in self-efficacy at baseline and week 5. | At baseline and week 5 | |
Secondary | Changes in cues to action | Will calculate frequencies for each cue to action (guided by the Health Belief Model). McNemar's tests will be used to calculate differences in the proportion of participants regarding each cue to action at baseline and week 5. | At baseline and week 5 | |
Secondary | Changes in air pollutant levels measured using the Flow 2 personal air quality sensor | Paired t-tests will determine changes in air pollutant levels at baseline and week 2 vs. week 4 and week 5. | At baseline and week 2 vs. week 4 and week 5 | |
Secondary | Intervention feasibility (accessibility) | Will report descriptive statistics for intervention accessibility based on responses to the relevant questionnaire items at week 5. | At week 5 | |
Secondary | Intervention feasibility (acceptability) | Will report descriptive statistics for intervention acceptability based on responses to the relevant questionnaire items at week 5. | At week 5 | |
Secondary | Intervention feasibility (demand) | Will report descriptive statistics for intervention demand based on responses to the relevant questionnaire items at week 5. | At week 5 | |
Secondary | Intervention feasibility (uptake, sensor upload completion) | Will report descriptive statistics the proportion of participants completing sensor uploads. | At baseline through week 5 | |
Secondary | Intervention feasibility (uptake, educational video viewing) | Will report descriptive statistics for the proportion of viewing educational videos at week 3. | At week 3 | |
Secondary | Intervention feasibility (uptake, questionnaire completion) | Will report descriptive statistics for the proportion of completing the questionnaires at baseline and week 5. | At baseline and week 5 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04931017 -
Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer
|
Phase 2 | |
Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
Not yet recruiting |
NCT06038526 -
Evaluation of Canakinumab in High-Risk Former-Smokers
|
Phase 2 | |
Terminated |
NCT02856581 -
Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes
|
Phase 3 | |
Recruiting |
NCT04644952 -
The Rise in Robotic Atypical Segmentectomies
|
||
Completed |
NCT01896778 -
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
|
N/A | |
Recruiting |
NCT05407168 -
Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
|
N/A | |
Completed |
NCT04267874 -
Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL Study
|
Early Phase 1 | |
Recruiting |
NCT02408861 -
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
|
Phase 1 | |
Recruiting |
NCT03709953 -
Efficacy and Safety of Apatinib as Third-line Therapy for Primary Pulmonary Lymphoepithelioid Carcinoma
|
Phase 2 | |
Active, not recruiting |
NCT03267524 -
Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers
|
N/A | |
Recruiting |
NCT04147494 -
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
|
Early Phase 1 | |
Completed |
NCT02237183 -
Iloprost in Preventing Lung Cancer in Former Smokers
|
Phase 1 | |
Recruiting |
NCT04783168 -
Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study
|
N/A | |
Completed |
NCT04635761 -
Awareness, Information, and Resources for Lung Cancer Screening Program for Community-Partnered Lung Cancer Screening
|
N/A | |
Recruiting |
NCT06445192 -
Evaluating the Impact of a Virtually Supervised Exercise Intervention and Group Counseling on Inflammation and the Microbiome of Smokers at High Risk for Lung Cancer, BE FIT Trial
|
N/A | |
Active, not recruiting |
NCT03164486 -
First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide
|
Early Phase 1 | |
Recruiting |
NCT05802186 -
Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
|
N/A | |
Active, not recruiting |
NCT01696968 -
Screening for Lung Cancer in Older Patients (PLCO Screening Trial)
|
N/A | |
Recruiting |
NCT04410302 -
Patient-Derived Xenografts to Reduce Cancer Health Disparities
|